A recent toast to James Watson highlights a tolerance for bigotry many want excised from the scientific community.
The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and to offer their insights.
January 2, 2018|
Thursday, March 8, 2018
2:30-4:00 PM Eastern Time
As the body’s circulating army of first responders, antibodies recognize and destroy foreign and potentially disease-causing pathogens. The engineering of synthetic antibody forms and conjugates has produced a whole new arsenal of tools for applications in research, diagnostics, and therapeutics. Forward-engineering approaches create new recognition sites and molecular functions for antibody products to accurately and efficiently detect previously undetectable molecular targets with an increased response lifetime. For a closer look at the fastest growing class of synthetic therapeutics, The Scientist is bringing together a panel of experts to share their research, discuss current design and optimization approaches, and to offer insight on the future outlook of antibody engineering. Join us as these experts share best practices and tips for optimally engineered antibodies.
Topics to be covered:
Anne Messer, PhD
Principal Investigator & Professor
Neural Stem Cell Institute
Regenerative Research Foundation
Department of Biomedical Sciences
University at Albany
Yasmina Abdiche, PhD